Cargando…
State of the Art in Tumor Antigen and Biomarker Discovery
Our knowledge of tumor immunology has resulted in multiple approaches for the treatment of cancer. However, a gap between research of new tumors markers and development of immunotherapy has been established and very few markers exist that can be used for treatment. The challenge is now to discover n...
Autores principales: | Even-Desrumeaux, Klervi, Baty, Daniel, Chames, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757432/ https://www.ncbi.nlm.nih.gov/pubmed/24212823 http://dx.doi.org/10.3390/cancers3022554 |
Ejemplares similares
-
Anti-NKG2D single domain-based antibodies for the modulation of anti-tumor immune response
por: Raynaud, Adeline, et al.
Publicado: (2020) -
Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies
por: Djender, Selma, et al.
Publicado: (2014) -
Therapeutic Antibodies for the Treatment of Pancreatic Cancer
por: Chames, Patrick, et al.
Publicado: (2010) -
Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?
por: Del Bano, Joanie, et al.
Publicado: (2015) -
A FcγRIII-engaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy
por: Turini, Marc, et al.
Publicado: (2014)